Clinical Profile of Critical Oncological Patients with COVID-19

Detalhes bibliográficos
Autor(a) principal: Oliveira, Ana Karoline Brito de
Data de Publicação: 2023
Outros Autores: Araújo, Matheus Sodré de, Alves, Samuel Filipe Lopes, Souza Filho, Luiz Euclides Coelho de, Silva , Marianne Lucena da, Cunha, Katiane da Costa
Tipo de documento: Artigo
Idioma: por
eng
spa
Título da fonte: Revista Brasileira de Cancerologia (Online)
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/3060
Resumo: Introduction: SARS-CoV-2 infection has a broad clinical spectrum, which can be categorized by its level of severity. Being an oncological patient is described in the literature as an important risk factor for more severe levels of the disease resulting from a state of immunosuppression. Objective: To compare demographic and clinical characteristics among cancer and non-cancer patients with COVID-19 in a referral hospital in the city of Belém, Pará. Method: Retrospective and quantitative study of analysis of medical records of patients diagnosed with COVID-19 between April and July 2020. For data analysis, the relative risk was calculated with a 95% confidence interval and test t. Results: The sample consisted in 53, mostly females (31; 58.49%) ICU patients diagnosed with COVID-19. There was a predominance of the outcome death for the group of cancer patients (27; 81.8%), as well as a greater number of non-neoplastic comorbidities among cancer patients (19; 57.5%). Cancer patients had longer invasive ventilatory support, with a mean of ten days (13; 39.39%). Conclusion: There were differences in demographic characteristics and interventions performed among the groups investigated.
id INCA-1_91192a7f6ced4d528dceb2427f739829
oai_identifier_str oai:rbc.inca.gov.br:article/3060
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
repository_id_str
spelling Clinical Profile of Critical Oncological Patients with COVID-19Perfil Clínico de Pacientes Oncológicos Críticos con Covid-19Perfil Clínico dos Pacientes Críticos Oncológicos com Covid-19COVID-19SARS-CoV-2neoplasiasunidades de terapia intensivaCOVID-19SARS-CoV-2neoplasmsintensive care unitsCOVID-19SARS-CoV-2neoplasiasunidades de cuidados intensivosIntroduction: SARS-CoV-2 infection has a broad clinical spectrum, which can be categorized by its level of severity. Being an oncological patient is described in the literature as an important risk factor for more severe levels of the disease resulting from a state of immunosuppression. Objective: To compare demographic and clinical characteristics among cancer and non-cancer patients with COVID-19 in a referral hospital in the city of Belém, Pará. Method: Retrospective and quantitative study of analysis of medical records of patients diagnosed with COVID-19 between April and July 2020. For data analysis, the relative risk was calculated with a 95% confidence interval and test t. Results: The sample consisted in 53, mostly females (31; 58.49%) ICU patients diagnosed with COVID-19. There was a predominance of the outcome death for the group of cancer patients (27; 81.8%), as well as a greater number of non-neoplastic comorbidities among cancer patients (19; 57.5%). Cancer patients had longer invasive ventilatory support, with a mean of ten days (13; 39.39%). Conclusion: There were differences in demographic characteristics and interventions performed among the groups investigated.Introducción: La infección por Sars-CoV-2 tiene un amplio espectro clínico, que se puede categorizar según su nivel de gravedad. Ser un paciente oncológico se describe en la literatura como un importante factor de riesgo para niveles más severos de la enfermedad derivados de un estado de inmunosupresión. Objetivo: Comparar las características demográficas y clínicas entre pacientes oncológicos y no oncológicos con covid-19 en un hospital de referencia en la ciudad de Belém, Pará. Método: Estudio retrospectivo y cuantitativo de análisis de historias clínicas de pacientes diagnosticados con covid-19, entre abril y julio de 2020. Para el análisis de datos se calculó el riesgo relativo con un intervalo de confianza del 95% y test t. Resultados: La muestra totalizó 53 pacientes de UCI diagnosticados con covid-19 e estaba compuesta principalmente por el sexo femenino (31; 58,49%). Predominó el desenlace de muerte en el grupo de pacientes oncológicos (27; 81,8%), así como un mayor número de comorbilidades no neoplásicas entre los pacientes oncológicos (19; 57,5%). Los pacientes con cáncer tuvieron soporte ventilatorio invasivo por más tiempo, con una media de diez días (13; 39,39 %). Conclusión: Hubo diferencias en las características demográficas y en las intervenciones realizadas entre los grupos estudiados.Introdução: A infecção por Sars-CoV-2 possui um amplo espectro clínico, que pode ser categorizado pelo seu nível de severidade. Ser paciente oncológico está descrito na literatura como fator de risco importante em níveis mais severos da doença decorrente do estado de imunossupressão. Objetivo: Comparar as características demográficas e clínicas entre pacientes oncológicos e não oncológicos com covid-19 em um hospital de referência na cidade de Belém, Pará. Método: Estudo retrospectivo e quantitativo de análise de prontuários de pacientes diagnosticados com covid-19 entre abril e julho de 2020. Para a análise dos dados, fez-se o cálculo do risco relativo com intervalo de confiança de 95% e teste t. Resultados: A amostra totalizou 53 pacientes da UTI diagnosticados com covid-19 e foi composta principalmente pelo sexo feminino (31; 58,49%). Houve predominância do desfecho óbito no grupo de pacientes oncológicos (27; 81,8%), assim como maior número de comorbidades não neoplásicas entre os pacientes oncológicos (19; 57,5%). Além disso, os pacientes oncológicos tiveram maior tempo de suporte ventilatório invasivo, com média de dez dias (13; 39,39%). Conclusão: Houve diferença nas características demográficas e nas intervenções realizadas entre os grupos estudados.INCA2023-01-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfapplication/pdfapplication/pdftext/htmlhttps://rbc.inca.gov.br/index.php/revista/article/view/306010.32635/2176-9745.RBC.2023v69n1.3060Revista Brasileira de Cancerologia; Vol. 69 No. 1 (2023): Jan./Feb./Mar.; e-133060Revista Brasileira de Cancerologia; Vol. 69 Núm. 1 (2023): ene./feb./mar.; e-133060Revista Brasileira de Cancerologia; v. 69 n. 1 (2023): jan./fev./mar.; e-1330602176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporengspahttps://rbc.inca.gov.br/index.php/revista/article/view/3060/2623https://rbc.inca.gov.br/index.php/revista/article/view/3060/3246https://rbc.inca.gov.br/index.php/revista/article/view/3060/2859https://rbc.inca.gov.br/index.php/revista/article/view/3060/2628Copyright (c) 2023 Revista Brasileira de Cancerologiahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessOliveira, Ana Karoline Brito deAraújo, Matheus Sodré deAlves, Samuel Filipe LopesSouza Filho, Luiz Euclides Coelho deSilva , Marianne Lucena daCunha, Katiane da Costa2023-10-31T13:59:23Zoai:rbc.inca.gov.br:article/3060Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2023-10-31T13:59:23Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Clinical Profile of Critical Oncological Patients with COVID-19
Perfil Clínico de Pacientes Oncológicos Críticos con Covid-19
Perfil Clínico dos Pacientes Críticos Oncológicos com Covid-19
title Clinical Profile of Critical Oncological Patients with COVID-19
spellingShingle Clinical Profile of Critical Oncological Patients with COVID-19
Oliveira, Ana Karoline Brito de
COVID-19
SARS-CoV-2
neoplasias
unidades de terapia intensiva
COVID-19
SARS-CoV-2
neoplasms
intensive care units
COVID-19
SARS-CoV-2
neoplasias
unidades de cuidados intensivos
title_short Clinical Profile of Critical Oncological Patients with COVID-19
title_full Clinical Profile of Critical Oncological Patients with COVID-19
title_fullStr Clinical Profile of Critical Oncological Patients with COVID-19
title_full_unstemmed Clinical Profile of Critical Oncological Patients with COVID-19
title_sort Clinical Profile of Critical Oncological Patients with COVID-19
author Oliveira, Ana Karoline Brito de
author_facet Oliveira, Ana Karoline Brito de
Araújo, Matheus Sodré de
Alves, Samuel Filipe Lopes
Souza Filho, Luiz Euclides Coelho de
Silva , Marianne Lucena da
Cunha, Katiane da Costa
author_role author
author2 Araújo, Matheus Sodré de
Alves, Samuel Filipe Lopes
Souza Filho, Luiz Euclides Coelho de
Silva , Marianne Lucena da
Cunha, Katiane da Costa
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Oliveira, Ana Karoline Brito de
Araújo, Matheus Sodré de
Alves, Samuel Filipe Lopes
Souza Filho, Luiz Euclides Coelho de
Silva , Marianne Lucena da
Cunha, Katiane da Costa
dc.subject.por.fl_str_mv COVID-19
SARS-CoV-2
neoplasias
unidades de terapia intensiva
COVID-19
SARS-CoV-2
neoplasms
intensive care units
COVID-19
SARS-CoV-2
neoplasias
unidades de cuidados intensivos
topic COVID-19
SARS-CoV-2
neoplasias
unidades de terapia intensiva
COVID-19
SARS-CoV-2
neoplasms
intensive care units
COVID-19
SARS-CoV-2
neoplasias
unidades de cuidados intensivos
description Introduction: SARS-CoV-2 infection has a broad clinical spectrum, which can be categorized by its level of severity. Being an oncological patient is described in the literature as an important risk factor for more severe levels of the disease resulting from a state of immunosuppression. Objective: To compare demographic and clinical characteristics among cancer and non-cancer patients with COVID-19 in a referral hospital in the city of Belém, Pará. Method: Retrospective and quantitative study of analysis of medical records of patients diagnosed with COVID-19 between April and July 2020. For data analysis, the relative risk was calculated with a 95% confidence interval and test t. Results: The sample consisted in 53, mostly females (31; 58.49%) ICU patients diagnosed with COVID-19. There was a predominance of the outcome death for the group of cancer patients (27; 81.8%), as well as a greater number of non-neoplastic comorbidities among cancer patients (19; 57.5%). Cancer patients had longer invasive ventilatory support, with a mean of ten days (13; 39.39%). Conclusion: There were differences in demographic characteristics and interventions performed among the groups investigated.
publishDate 2023
dc.date.none.fl_str_mv 2023-01-31
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artigos, Avaliado pelos pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/3060
10.32635/2176-9745.RBC.2023v69n1.3060
url https://rbc.inca.gov.br/index.php/revista/article/view/3060
identifier_str_mv 10.32635/2176-9745.RBC.2023v69n1.3060
dc.language.iso.fl_str_mv por
eng
spa
language por
eng
spa
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/3060/2623
https://rbc.inca.gov.br/index.php/revista/article/view/3060/3246
https://rbc.inca.gov.br/index.php/revista/article/view/3060/2859
https://rbc.inca.gov.br/index.php/revista/article/view/3060/2628
dc.rights.driver.fl_str_mv Copyright (c) 2023 Revista Brasileira de Cancerologia
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Revista Brasileira de Cancerologia
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
text/html
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 69 No. 1 (2023): Jan./Feb./Mar.; e-133060
Revista Brasileira de Cancerologia; Vol. 69 Núm. 1 (2023): ene./feb./mar.; e-133060
Revista Brasileira de Cancerologia; v. 69 n. 1 (2023): jan./fev./mar.; e-133060
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1797042233907609600

Registros relacionados